Drug intelligence / Profile preview

CIL-005

Development stage: Unknown
Lead developer: Cilcare
Modality: Small Molecules

Overview

CIL-005 is a chemical drug candidate developed by Cilcare SAS. It is currently in the discovery phase of research and development. Specific details regarding its mechanism of action, molecular target(s), therapeutic area(s), or intended indications have not been publicly disclosed as of the latest available update (March 2025). The compound has not yet entered clinical trials or received regulatory approval[1].

Other names: CIL005CIL-005CIL 005

Beyond the preview

Go deeper on CIL-005.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CIL-005.

Explore the full profile